HHSIndustrials · Conglomerates

HHS Stock Forecast: Harte-Hanks, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026

$3.73

+3.32% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 30 of 100 as at 22 Aug 2026 — in the lower half.

Market cap

$27.4M

Ticker Nerd rank

30 / 100

Median analyst target

—

Analysts covering

Total return, dividends reinvested

−13.3%

+52.2%

YTD

+23.9%

+4.5%

From 52W high

−13.3%

From 52W low

+86.5%

$2.00

$4.30

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

HHS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Harte-Hanks, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026

30 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals

Size

Momentum

Issuance

Quality

Value

Volatility

Revisions

Growth

Accruals (92): Reported profit is backed by cash, and the company is not expanding recklessly.

Growth (8): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HHS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HHS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
9 Nov 2017	Noble Capital Markets	Upgrade	Buy	—
14 Mar 2016	BMO Capital	Downgrade	Market Perform	—
8 Dec 2015	Singular Research	Initiates	Buy	—
21 July 2015	BMO Capital	Upgrade	Outperform	—
30 May 2014	BMO Capital	Downgrade	Market Perform	—
21 Oct 2013	Noble Capital Markets	Downgrade	Hold	—
4 Oct 2013	BMO Capital	Upgrade	Outperform	—
26 Apr 2013	Noble Capital Markets	Upgrade	Buy	—
1 Feb 2013	BMO Capital	Maintains	Market Perform	—
1 Feb 2013	Noble Capital Markets	Downgrade	Hold	—
26 Oct 2012	BMO Capital	Maintains	Market Perform	—
26 Oct 2012	Noble Capital Markets	Upgrade	Buy	—
18 July 2012	Noble Capital Markets	Downgrade	Hold	—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HHS appears on the weeks it earns a place.

Estimates

HHS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Harte-Hanks, Inc. (HHS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 2.3×
Price / sales: 0.2×
Price / book: 1.3×
EV / EBITDA: −116.0×

Growth & margins

Revenue growth (YoY): −1.7%
Earnings growth (YoY): −10.3%
Gross margin: 69.6%
Operating margin: −12.2%
Net margin: −3.7%

Returns & dividend

Return on equity: −30.4%
Return on assets: −3.4%
Dividend yield: 92.4%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

HHS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelConglomerates

Company	Market cap	TKN rank
HHSHarte-Hanks, Inc.	$27.4M	30
LGPSLogProstyle, Inc.	$21.3M	48
GPUSHyperscale Data, Inc.	$45.5M	10
PLAGPlanet Green Holdings Corp.	$9.7M	38
AIRTAir T, Inc.	$77.5M	41
BOOMDMC Global, Inc.	$144.0M	47
TUSKMammoth Energy Services, Inc.	$147.4M	23

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Harte-Hanks, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HHS news & analysis

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

PRNewsWire · 14 Aug 2026negative

Ademi LLP announced it is investigating Harte Hanks, Inc. for possible breaches of fiduciary duty and other violations of law related to the company's recently announced transaction with Star Equity. The firm is seeking additional shareholders to join the investigation.

Why it matters — A shareholder law firm has opened a fiduciary-duty investigation into the proposed Star Equity transaction, which could bring scrutiny to the deal's terms and fairness for public shareholders.

HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders

Business Wire · 14 Aug 2026negative

Halper Sadeh LLC, an investor rights law firm, is investigating whether Harte Hanks, Inc. is obtaining a fair price in its proposed sale to Star Equity Holdings, Inc. Under the deal, Harte Hanks shareholders may choose $5.00 per share in cash or 0.50 shares of Star Equity preferred stock per Harte Hanks share.

Why it matters — The investigation raises the possibility that Harte Hanks shareholders may not be receiving adequate consideration in the proposed transaction.

Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks

GlobeNewsWire · 14 Aug 2026positive

Star Equity Holdings has entered into a merger agreement to acquire Harte Hanks, a global customer experience and business process outsourcing company. Harte Hanks stockholders will receive $5.00 per share, consisting of cash and Star preferred stock.

Why it matters — Harte Hanks stockholders will receive a defined $5.00 per share offer as the company is acquired by Star Equity Holdings, expanding Star's business services platform and enhancing revenue diversity.

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Accesswire · 14 Aug 2026positive

Harte Hanks has entered into a definitive merger agreement to be acquired by Star Equity Holdings for $5.00 per share, representing approximately $38.4 million in aggregate equity value. The transaction will be paid 50% in cash and 50% in Star Equity 10% preferred stock, and has been unanimously approved by Harte Hanks' Board of Directors.

Why it matters — The acquisition at a roughly 100% premium to Harte Hanks' unaffected share price means shareholders are being offered significantly more than the stock's recent market value.

Former CDC Official on the Cyclospora Outbreak

Bloomberg Markets and Finance · 13 Aug 2026negative

A former CDC official discussed the cyclospora outbreak, noting a disconnect between HHS's declaration that the outbreak is contained and salad is safe, and CDC data showing a 33% increase in confirmed cases with nearly 14,000 reported and 10,000 more under investigation.

Why it matters — HHS watchers would care because the apparent contradiction between HHS's public statements and CDC's data raises questions about the department's crisis communication and internal coordination.

FAQ

Frequently asked questions about HHS stock

Is HHS stock a buy right now?

Of the 1 analysts covering Harte-Hanks, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Harte-Hanks, Inc. 30 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HHS?

As at 22 Aug 2026, Harte-Hanks, Inc. ranks 30 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (92 of 100).

What is the HHS stock forecast for 2030?

No analyst covering Harte-Hanks, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HHS are extrapolating price history, which says nothing about the business.

How has HHS stock performed over the past year?

Harte-Hanks, Inc. returned +4.5% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Harte-Hanks, Inc. do?

Harte-Hanks Inc. is a renowned marketing services company that specializes in multi-channel marketing solutions and customer interaction services.

What is the latest news on HHS?

The most recent item we track (PRNewsWire, 14 Aug 2026): "Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders". Ademi LLP announced it is investigating Harte Hanks, Inc. for possible breaches of fiduciary duty and other violations of law related to the company's recently announced transaction with Star Equity. The firm is seeking additional shareholders to join the investigation.

Company

About Harte-Hanks, Inc.

Harte-Hanks Inc. is a renowned marketing services company that specializes in multi-channel marketing solutions and customer interaction services. Its primary function is to assist businesses in achieving higher customer engagement and loyalty through innovative marketing strategies and data-driven insights. The company operates across various sectors, including retail, financial services, automotive, and healthcare, providing tailored solutions that enhance brand presence and performance. Harte-Hanks is noted for its ability to integrate traditional and digital marketing channels, offering services such as data management, analytics, customer care, and digital marketing. This versatility allows it to cater to a diverse clientele, addressing complex marketing challenges with precision and efficiency. In the financial market, Harte-Hanks plays a significant role by driving marketing transformation and empowering businesses with actionable intelligence. Its expertise in harnessing data to propel advertising campaigns is a valuable asset to companies navigating an increasingly competitive marketplace. Headquartered in the United States, Harte-Hanks continues to evolve, leveraging its rich history and expertise to remain at the forefront of the marketing services industry.

CEO Mr. Kirk A. Davis · 1,719 employees · United States · https://www.hartehanks.com